Search Results - "Yoshie, Reiko"

Replication Study for the Association of Five SNPs Identified by GWAS and Trastuzumab-Induced Cardiotoxicity in Japanese and Singaporean Cohorts by Udagawa, Chihiro, Kuah, Sherwin, Shimoi, Tatsunori, Kato, Ken, Yoshida, Teruhiko, Nakano, Mari Hara, Shimo, Arata, Kojima, Yasuyuki, Yoshie, Reiko, Tsugawa, Koichiro, Mushiroda, Taisei, Tan, Ern Yu, Zembutsu, Hitoshi

“…Trastuzumab (herceptin) is an effective drug for human epidermal growth factor receptor type 2 (HER2)-positive cancer. However, cardiotoxicity remains a…”
Get full text

Oncologic outcomes and technical considerations of nipple-sparing mastectomies in breast cancer: experience of 425 cases from a single institution by Shimo, Ayaka, Tsugawa, Koichiro, Tsuchiya, Seiko, Yoshie, Reiko, Tsuchiya, Kyoko, Uejima, Tomoko, Kojima, Yasuyuki, Shimo, Arata, Hayami, Ryosuke, Nishikawa, Toru, Yabuki, Yukari, Kawamoto, Hisanori, Sudo, Akihiko, Fukuda, Mamoru, Kanemaki, Yoshihide, Maeda, Ichiro

“…Background Nipple-sparing mastectomy (NSM) is an advantageous treatment option, providing a complete cure and good cosmetic results. We tested whether NSM is a…”
Get full text

A Genome-Wide Association Study Identifies Five Novel Genetic Markers for Trastuzumab-Induced Cardiotoxicity in Japanese Population by Nakano, Mari Hara, Udagawa, Chihiro, Shimo, Arata, Kojima, Yasuyuki, Yoshie, Reiko, Zaha, Hisamitsu, Abe, Norie, Motonari, Tokiwa, Unesoko, Mikiko, Tamura, Kenji, Shimoi, Tatsunori, Yoshida, Masayuki, Yoshida, Teruhiko, Sakamoto, Hiromi, Kato, Ken, Mushiroda, Taisei, Tsugawa, Koichiro, Zembutsu, Hitoshi

“…Trastuzumab has been administered to patients with human epidermal growth factor receptor 2 (HER2)-positive cancer, however, the cardiotoxicity is identified…”
Get full text

P3-013A phase 1b study of S-1 combined with trastuzumab emtansine (T-DM1) for HER2 positive metastatic breast cancer by Kojima, Yasuyuki, Yoshie, Reiko, Kawamoto, Hisanori, Shimo, Arata, Uejima, Tomoko, Iwatani, Tsuguo, Motoyoshi, Ai, Haku, Ei, Kanemaki, Yoshihide, Tsugawa, Koichiro

Get full text

A phase 1b study of S-1 combined with trastuzumab emtansine (T-DM1) for HER2 positive metastatic breast cancer by Kojima, Yasuyuki, Yoshie, Reiko, Kawamoto, Hisanori, Shimo, Arata, Uejima, Tomoko, Iwatani, Tsuguo, Motoyoshi, Ai, Haku, Ei, Kanemaki, Yoshihide, Tsugawa, Koichiro

Get full text

Abstract 2951: A genome-wide association study identifies five novel genetic markers for trastuzumab-induced cardiotoxicity by Udagawa, Chihiro, Hara, Mari, Shimo, Arata, Kojima, Yasuyuki, Yoshie, Reiko, Zaha, Hisamitsu, Abe, Norie, Motonari, Tokiwa, Unesoko, Mikiko, Tamura, Kenji, Shimoi, Tatsunori, Yoshida, Masayuki, Yoshida, Teruhiko, Okamura, Hiroshi, Mushiroda, Taisei, Tsugawa, Koichiro, Zembutsu, Hitoshi

“…Purpose: Trastuzumab has been administered to HER2-positive breast or gastric cancer patients as an effective treatment, however, the cardiotoxicity is…”
Get full text

A Genome-Wide Association Study Identifies Five Novel Genetic Markers for Trastuzumab-Induced Cardiotoxicity in Japanese Population by Nakano, Mari Hara, Udagawa, Chihiro, Shimo, Arata, Kojima, Yasuyuki, Yoshie, Reiko, Zaha, Hisamitsu, Abe, Norie, Motonari, Tokiwa, Unesoko, Mikiko, Tamura, Kenji, Shimoi, Tatsunori, Yoshida, Masayuki, Yoshida, Teruhiko, Sakamoto, Hiromi, Kato, Ken, Mushiroda, Taisei, Tsugawa, Koichiro, Zembutsu, Hitoshi

“…Trastuzumab has been administered to patients with HER2-positive cancer, however, the cardiotoxicity is identified as one of the life-threatening toxicities…”
Get full text